Human Reproduction, Vol. 14, No. 3, 793-799,
March 1999
© 1999 European Society of Human Reproduction and Embryology
Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel
Department of Obstetrics and Gynaecology, Centre for Reproductive Biology, The University of Edinburgh, 37 Chalmers Street, Edinburgh EH3 9EW, UK
Remodelling of endometrial tissues is fundamental to the cyclical changes that occur during the menstrual cycle, implantation and, in the absence of pregnancy, at menstruation. The enzyme matrix metalloproteinase-9 (MMP-9) is recognized as important in these processes but its regulation is not well defined. These studies have demonstrated that MMP-9 activity is present in the endometrium and exhibits cyclical changes in its distribution in the glandular and stromal cells. MMP-9 protein is present throughout the cycle with highest expression, as determined by semi-quantitative analysis of specific MMP-9 immunoreactivity, in glandular cells during the mid secretory phase. A similar distribution was observed in first trimester decidua. In women with a levonorgestrel intrauterine system (LNG-IUS), which delivers high local concentrations of progestagen to the uterine cavity, MMP-9 is highly expressed in both endometrial glandular and stromal cells, and in the vasculature (in endothelial and perivascular cells). It can be concluded that MMP-9 is stimulated directly or indirectly by progesterone. Furthermore, MMP-9 may play a role in the remodelling of the endometrium that occurs during the menstrual cycle and in the aetiology of the morphological changes and breakthrough bleeding associated with long-term progestagen administration via a LNG-IUS.
Key words: contraception–LNG/endometrium/matrix metalloproteinases/menstruation/tissue remodelling
1 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Labied, C. Galant, M. Nisolle, S. Ravet, C. Munaut, E. Marbaix, J.-M. Foidart, and F. Frankenne Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., January 1, 2009; 24(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Stephanie, S. Labied, S. Blacher, F. Frankenne, C. Munaut, V. Fridman, A. Beliard, J.-M. Foidart, and M. Nisolle Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., December 1, 2007; 22(12): 3084 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. B Morison, J. Zhang, T. J Kaitu'u-Lino, I. S Fraser, and L. A Salamonsen The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women Reproduction, January 1, 2007; 133(1): 309 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Collette, R. Maheux, J. Mailloux, and A. Akoum Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis Hum. Reprod., December 1, 2006; 21(12): 3059 - 3067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hickey, J. Crewe, L. A. Mahoney, D. A. Doherty, I. S. Fraser, and L. A. Salamonsen Mechanisms of Irregular Bleeding with Hormone Therapy: The Role of Matrix Metalloproteinases and Their Tissue Inhibitors J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3189 - 3198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wahab, A.H. Taylor, J.H. Pringle, J. Thompson, and F. Al-Azzawi Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell Mol. Hum. Reprod., March 1, 2006; 12(3): 157 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Kaitu'u, J. Shen, J. Zhang, N. B. Morison, and L. A. Salamonsen Matrix Metalloproteinases in Endometrial Breakdown and Repair: Functional Significance in a Mouse Model Biol Reprod, October 1, 2005; 73(4): 672 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Cornet, C. Galant, Y. Eeckhout, P. J. Courtoy, E. Marbaix, and P. Henriet Regulation of Matrix Metalloproteinase-9/Gelatinase B Expression and Activation by Ovarian Steroids and LEFTY-A/Endometrial Bleeding-Associated Factor in the Human Endometrium J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1001 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Plaisier, K. Kapiteijn, P. Koolwijk, C. Fijten, R. Hanemaaijer, J. M. Grimbergen, A. Mulder-Stapel, P. H. A. Quax, F. M. Helmerhorst, and V. W. M. van Hinsbergh Involvement of Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Capillary Tube Formation by Human Endometrial Microvascular Endothelial Cells: Role of MT3-MMP J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5828 - 5836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Oliveira-Ribeiro, C. A. Petta, L. A.L. De Angelo Andrade, L. Bahamondes, and M. M. Hidalgo Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system Hum. Reprod., August 1, 2004; 19(8): 1778 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Coppock, A. White, J. D. Aplin, and M. Westwood Matrix Metalloprotease-3 and -9 Proteolyze Insulin-Like Growth Factor-Binding Protein-1 Biol Reprod, August 1, 2004; 71(2): 438 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. McGavigan, P. Dockery, V. Metaxa-Mariatou, D. Campbell, C. J.R. Stewart, I. T. Cameron, and S. Campbell Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel Hum. Reprod., January 1, 2003; 18(1): 77 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Jokimaa, S. Oksjoki, H. Kujari, E. Vuorio, and L. Anttila Altered expression of genes involved in the production and degradation of endometrial extracellular matrix in patients with unexplained infertility and recurrent miscarriages Mol. Hum. Reprod., December 1, 2002; 8(12): 1111 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Cornet, C. Picquet, P. Lemoine, K. G. Osteen, K. L. Bruner-Tran, S. Tabibzadeh, P. J. Courtoy, Y. Eeckhout, E. Marbaix, and P. Henriet Regulation and Function of LEFTY-A/EBAF in the Human Endometrium. mRNA EXPRESSION DURING THE MENSTRUAL CYCLE, CONTROL BY PROGESTERONE, AND EFFECT ON MATRIX METALLOPROTEINASES J. Biol. Chem., November 1, 2002; 277(45): 42496 - 42504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.A. Cork, E.M. Tuckerman, T.C. Li, and S.M. Laird Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro Mol. Hum. Reprod., September 1, 2002; 8(9): 841 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum. Reprod., May 1, 2002; 17(5): 1189 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.A. Milne, A. Rakhyoot, T.A. Drudy, S. Brechin, S.C. Riley, and H.O.D. Critchley Co-localization of matrix metalloproteinase-1 and mast cell tryptase in the human uterus Mol. Hum. Reprod., June 1, 2001; 7(6): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Jokimaa, S. Oksjoki, H. Kujari, E. Vuorio, and L. Anttila Expression patterns of cathepsins B, H, K, L and S in the human endometrium Mol. Hum. Reprod., January 1, 2001; 7(1): 73 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hickey, D. Dwarte, and I.S. Fraser Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding Hum. Reprod., July 1, 2000; 15(7): 1509 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives Hum. Reprod., January 1, 2000; 15(1): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-A. Ledingham, F. C. Denison, S. C. Riley, and J. E. Norman Matrix metalloproteinases-2 and -9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors Hum. Reprod., August 1, 1999; 14(8): 2089 - 2096. [Abstract] [Full Text] [PDF]
|
|